gb_flag germany_flag japan_flag korea_flag china_flag
Back to Knowledge Bank
Webinars and Videos

Clinical trials, inventive step and insufficiency ǀ European biotech patent case law series (November 2024)

Simon O'Brien
Simon O'Brien
Partner, Patent Attorney
Nathaniel Wand
Nathaniel Wand
Senior Associate, Patent Attorney

European patent attorneys Simon O'Brien and Nathaniel Wand present our latest webinar update of new and important European Patent Office (EPO) biotechnology patent case law.

Dyoung webinar biotech7

The webinar includes discussion of the latest European biotech patent case law developments including:

  • T1437/21: novelty and inventive step of treating a patient subpopulation in view of prior art of a phase 3 clinical trial.
  • T1941/21: inventive step over clinical trial protocol and novelty over combination therapy.
  • T0197/22: insufficieny of a first medical claim.

System requirements

To view our webinars we recommend the following internet browsers:

  • Google Chrome (most recent 2 versions).
  • Mozilla Firefox (most recent 2 versions).
  • Apple Safari (most recent 2 versions).
  • Microsoft Edge (most recent 2 versions).
Patent newsletter Latest edition
Patent newsletter Latest edition
Latest newsletter